Commerce Bank Biocryst Pharmaceuticals Inc Transaction History

Commerce Bank

  • $16.1 Billion
  • Q3 2024

A detailed history of Commerce Bank transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Commerce Bank holds 31,275 shares of BCRX stock, worth $233,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,275
Previous 32,310 3.2%
Holding current value
$233,311
Previous $199,000 19.1%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$6.41 - $8.69 $6,634 - $8,994
-1,035 Reduced 3.2%
31,275 $237,000
Q1 2024

May 03, 2024
BUY
$4.89 - $7.65 $66,724 - $104,384
13,645 Added 73.1%
32,310 $164,000
Q4 2023

Feb 09, 2024
SELL
$4.98 - $6.77 $4,457 - $6,059
-895 Reduced 4.58%
18,665 $111,000
Q3 2023

Nov 13, 2023
SELL
$6.71 - $7.92 $3,724 - $4,395
-555 Reduced 2.76%
19,560 $138,000
Q2 2023

Aug 08, 2023
SELL
$6.96 - $8.81 $1,740 - $2,202
-250 Reduced 1.23%
20,115 $141,000
Q1 2023

May 04, 2023
BUY
$7.94 - $11.84 $45,734 - $68,198
5,760 Added 39.44%
20,365 $169,000
Q4 2022

Feb 10, 2023
BUY
$10.5 - $14.2 $44,467 - $60,137
4,235 Added 40.84%
14,605 $167,000
Q3 2022

Nov 04, 2022
BUY
$10.79 - $14.81 $111,892 - $153,579
10,370 New
10,370 $130,000
Q2 2022

Aug 12, 2022
SELL
$7.89 - $17.88 $157,800 - $357,600
-20,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$11.18 - $15.46 $55,900 - $77,300
5,000 Added 33.33%
20,000 $277,000
Q3 2021

Nov 09, 2021
BUY
$14.21 - $17.65 $213,150 - $264,750
15,000 New
15,000 $216,000

Others Institutions Holding BCRX

# of Institutions
279
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email